243 related articles for article (PubMed ID: 25704921)
1. Suppression of CYP2C9 by microRNA hsa-miR-128-3p in human liver cells and association with hepatocellular carcinoma.
Yu D; Green B; Marrone A; Guo Y; Kadlubar S; Lin D; Fuscoe J; Pogribny I; Ning B
Sci Rep; 2015 Feb; 5():8534. PubMed ID: 25704921
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of microRNA-338-3p promoted angiogenesis in hepatocellular carcinoma.
Zhang T; Liu W; Zeng XC; Jiang N; Fu BS; Guo Y; Yi HM; Li H; Zhang Q; Chen WJ; Chen GH
Biomed Pharmacother; 2016 Dec; 84():583-591. PubMed ID: 27694002
[TBL] [Abstract][Full Text] [Related]
3. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
[TBL] [Abstract][Full Text] [Related]
4. A systematic evaluation of microRNAs in regulating human hepatic CYP2E1.
Wang Y; Yu D; Tolleson WH; Yu LR; Green B; Zeng L; Chen Y; Chen S; Ren Z; Guo L; Tong W; Guan H; Ning B
Biochem Pharmacol; 2017 Aug; 138():174-184. PubMed ID: 28438567
[TBL] [Abstract][Full Text] [Related]
5. Circular RNA hsa_circ_0000673 promotes hepatocellular carcinoma malignance by decreasing miR-767-3p targeting SET.
Jiang W; Wen D; Gong L; Wang Y; Liu Z; Yin F
Biochem Biophys Res Commun; 2018 Jun; 500(2):211-216. PubMed ID: 29627570
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA hsa-miR-25-3p suppresses the expression and drug induction of CYP2B6 in human hepatocytes.
Jin Y; Yu D; Tolleson WH; Knox B; Wang Y; Chen S; Ren Z; Deng H; Guo Y; Ning B
Biochem Pharmacol; 2016 Aug; 113():88-96. PubMed ID: 27311985
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of c-FLIP expression by miR-512-3p contributes to taxol-induced apoptosis in hepatocellular carcinoma cells.
Chen F; Zhu HH; Zhou LF; Wu SS; Wang J; Chen Z
Oncol Rep; 2010 May; 23(5):1457-62. PubMed ID: 20372864
[TBL] [Abstract][Full Text] [Related]
8. Hsa-miR-331-3p inhibits VHL expression by directly targeting its mRNA 3'-UTR in HCC cell lines.
Cao Y; Zhang J; Xiong D; Wang D; Wu T; Huang A; Tang H
Acta Biochim Pol; 2015; 62(1):77-82. PubMed ID: 25750939
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-155-3p promotes hepatocellular carcinoma formation by suppressing FBXW7 expression.
Tang B; Lei B; Qi G; Liang X; Tang F; Yuan S; Wang Z; Yu S; He S
J Exp Clin Cancer Res; 2016 Jun; 35(1):93. PubMed ID: 27306418
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-34c-3p promotes cell proliferation and invasion in hepatocellular carcinoma by regulation of NCKAP1 expression.
Xiao CZ; Wei W; Guo ZX; Zhang MY; Zhang YF; Wang JH; Shi M; Wang HY; Guo RP
J Cancer Res Clin Oncol; 2017 Feb; 143(2):263-273. PubMed ID: 27704267
[TBL] [Abstract][Full Text] [Related]
11. [The effects of microRNA-7 on proliferation and invasion of hepatocellular carcinoma HepG2 cells].
Qin AD; Liu XX; Li J; Liu J; Li YS
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):406-411. PubMed ID: 29936764
[No Abstract] [Full Text] [Related]
12. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.
Buurman R; Gürlevik E; Schäffer V; Eilers M; Sandbothe M; Kreipe H; Wilkens L; Schlegelberger B; Kühnel F; Skawran B
Gastroenterology; 2012 Sep; 143(3):811-820.e15. PubMed ID: 22641068
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma.
Wu G; Zheng K; Xia S; Wang Y; Meng X; Qin X; Cheng Y
J Exp Clin Cancer Res; 2016 Jun; 35(1):89. PubMed ID: 27259866
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA hsa-miR-370-3p suppresses the expression and induction of CYP2D6 by facilitating mRNA degradation.
Zeng L; Chen Y; Wang Y; Yu LR; Knox B; Chen J; Shi T; Chen S; Ren Z; Guo L; Wu Y; Liu D; Huang K; Tong W; Yu D; Ning B
Biochem Pharmacol; 2017 Sep; 140():139-149. PubMed ID: 28552654
[TBL] [Abstract][Full Text] [Related]
15. Modulation of ALDH5A1 and SLC22A7 by microRNA hsa-miR-29a-3p in human liver cells.
Yu D; Tolleson WH; Knox B; Jin Y; Guo L; Guo Y; Kadlubar SA; Ning B
Biochem Pharmacol; 2015 Dec; 98(4):671-80. PubMed ID: 26428001
[TBL] [Abstract][Full Text] [Related]
16. Inflammation-associated microRNA-130b down-regulates cytochrome P450 activities and directly targets CYP2C9.
Rieger JK; Reutter S; Hofmann U; Schwab M; Zanger UM
Drug Metab Dispos; 2015 Jun; 43(6):884-8. PubMed ID: 25802328
[TBL] [Abstract][Full Text] [Related]
17. LINC00052/miR-101-3p axis inhibits cell proliferation and metastasis by targeting SOX9 in hepatocellular carcinoma.
Yan S; Shan X; Chen K; Liu Y; Yu G; Chen Q; Zeng T; Zhu L; Dang H; Chen F; Ling J; Huang A; Tang H
Gene; 2018 Dec; 679():138-149. PubMed ID: 30098428
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.
Zhao G; Wang T; Huang QK; Pu M; Sun W; Zhang ZC; Ling R; Tao KS
World J Gastroenterol; 2016 Jun; 22(23):5364-73. PubMed ID: 27340352
[TBL] [Abstract][Full Text] [Related]
19. miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC.
Zhao N; Sun H; Sun B; Zhu D; Zhao X; Wang Y; Gu Q; Dong X; Liu F; Zhang Y; Li X
Sci Rep; 2016 Mar; 6():23091. PubMed ID: 26980408
[TBL] [Abstract][Full Text] [Related]
20. Methylation-associated silencing of microRNA-129-3p promotes epithelial-mesenchymal transition, invasion and metastasis of hepatocelluar cancer by targeting Aurora-A.
Cui S; Zhang K; Li C; Chen J; Pan Y; Feng B; Lu L; Zhu Z; Wang R; Chen L
Oncotarget; 2016 Nov; 7(47):78009-78028. PubMed ID: 27793005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
